| Janssen-Cilag AG - Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung | | 69974 | | 01 | | Tremfya 200 mg/20 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L04AC16 | | Guselkumab | | 10.06.2025 | | |
| | Composition | | guselkumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, methioninum, dinatrii edetas corresp. natrium 0.05 mg, aqua ad iniectabile q.s. ad solutionem pro 20 ml. | | Packungsbestandteile | | Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Guselkumabum | 200mg / 20ml |
| | | | Inactive agents |
|---|
| Dinatrii Edetas | | Histidin Hydrochloride Monohydrate | | Histidine | | Methionine | | Polysorbatum 80 | | Saccharum |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | B | | No |
|
|
